Skip to content
value.today

Teleflex Incorporated: peers

Change the peers

Teleflex Incorporated beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Teleflex Incorporated, Merit Medical Systems, Inc., Haemonetics Corporation, iRhythm Technologies, Inc., ICU Medical, Inc., Pulse Biosciences, Inc., Envista Holdings Corporation, AtriCure, Inc. side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureTeleflex Incorporatedbase
TFX · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Merit Medical Systems, Inc.
MMSI · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Haemonetics Corporation
HAE · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
iRhythm Technologies, Inc.
IRTC · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
ICU Medical, Inc.
ICUI · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Pulse Biosciences, Inc.
PLSE · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Envista Holdings Corporation
NVST · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
AtriCure, Inc.
ATRC · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Group median
Size
Market cap (Better neither way: ranked highest first)$5.5 BOct 28, 2026 · Market data2nd of 8$5.6 BOct 26, 2026 · Market data1st of 8$5.5 BOct 28, 2026 · Market data3rd of 8$4.3 BOct 30, 2026 · Market data4th of 8$3.9 BOct 9, 2026 · Market data5th of 8$3.9 BOct 27, 2026 · Market data6th of 8$3.8 BOct 28, 2026 · Market data7th of 8$3.1 BOct 29, 2026 · Market data8th of 8$4.1 B8 ranked
Revenue (Better neither way: ranked highest first)$2.0 BFY2025 · SEC3rd of 8$1.5 BFY2025 · SEC4th of 8$1.3 BFY2025 · SEC5th of 8$747 MFY2025 · SEC6th of 8$2.2 BFY2025 · SEC2nd of 8$0 MFY2025 · SEC8th of 8$2.7 BFY2025 · SEC1st of 8$535 MFY2025 · SEC7th of 8$1.4 B8 ranked
Net income (Higher is better)$-906 MFY2025 · SEC8th of 8$128 MFY2025 · SEC1st of 8$97 MFY2025 · SEC2nd of 8$-45 MFY2025 · SEC6th of 8$1 MFY2025 · SEC4th of 8$-73 MFY2025 · SEC7th of 8$47 MFY2025 · SEC3rd of 8$-11 MFY2025 · SEC5th of 8$-5 M8 ranked
Employees (Better neither way: ranked highest first)15,500As on 2022 · Profile1st of 76,446As on 2021 · Profile4th of 73,034As on 2022 · Profile5th of 71,700As on 2021 · Profile6th of 78,500As on 2021 · Profile3rd of 7——12,700As on 2022 · Profile2nd of 7875As on 2021 · Profile7th of 76,4467 ranked
Growth
Market cap change, 30 days (Higher is better)——+6.6%30 days to Oct 26, 2026 · Market data1st of 2————————-2.0%30 days to Oct 28, 2026 · Market data2nd of 2——+2.3%2 ranked
Revenue growth (Higher is better)+17.3%FY2025 · SEC2nd of 763rd75th+11.8%FY2025 · SEC4th of 754th65th-2.0%FY2025 · SEC6th of 722nd24th+26.2%FY2025 · SEC1st of 774th84th-6.3%FY2025 · SEC7th of 716th16th————+8.3%FY2025 · SEC5th of 746th56th+14.9%FY2025 · SEC3rd of 759th71st+11.8%7 ranked
Revenue growth, 3 years a year (Higher is better)-10.6%FY2025 · SEC7th of 711th10th+9.6%FY2025 · SEC3rd of 752nd68th+4.5%FY2025 · SEC4th of 740th51st+22.1%FY2025 · SEC1st of 774th87th-0.7%FY2025 · SEC6th of 725th30th————+1.9%FY2025 · SEC5th of 732nd40th+17.4%FY2025 · SEC2nd of 768th82nd+4.5%7 ranked
Earnings per share growth (Higher is better)————+4.9%FY2025 · SEC1st of 244th44th-38.1%FY2025 · SEC2nd of 213th13th————————————————————-16.6%2 ranked
Margins and returns
Gross margin (Higher is better)56.2%FY2025 · SEC4th of 746th70th48.7%FY2025 · SEC6th of 734th62nd59.0%FY2025 · SEC3rd of 751st73rd70.6%FY2025 · SEC2nd of 769th83rd36.8%FY2025 · SEC7th of 722nd46th————54.7%FY2025 · SEC5th of 743rd68th75.0%FY2025 · SEC1st of 775th87th56.2%7 ranked
Operating margin (Higher is better)5.9%FY2025 · SEC4th of 766th58th12.2%FY2025 · SEC1st of 776th73rd11.8%FY2025 · SEC2nd of 776th72nd-7.7%FY2025 · SEC7th of 750th29th1.9%FY2025 · SEC5th of 761st45th————8.0%FY2025 · SEC3rd of 769th63rd-1.8%FY2025 · SEC6th of 755th37th5.9%7 ranked
Net margin (Higher is better)-45.5%FY2025 · SEC7th of 732nd15th8.5%FY2025 · SEC1st of 776th71st7.3%FY2025 · SEC2nd of 774th68th-6.0%FY2025 · SEC6th of 752nd32nd0.0%FY2025 · SEC4th of 760th43rd————1.7%FY2025 · SEC3rd of 764th49th-2.1%FY2025 · SEC5th of 757th38th0.0%7 ranked
Free cash flow margin (Higher is better)0.1%FY2025 · SEC7th of 752nd34th14.2%FY2025 · SEC2nd of 780th79th19.5%FY2025 · SEC1st of 787th87th4.6%FY2025 · SEC5th of 762nd52nd4.1%FY2025 · SEC6th of 761st50th————8.5%FY2025 · SEC4th of 768th66th9.0%FY2025 · SEC3rd of 770th68th8.5%7 ranked
Return on equity (Higher is better)-24.5%FY2025 · SEC6th of 858th26th8.7%FY2025 · SEC2nd of 879th60th12.0%FY2025 · SEC1st of 884th71st-36.6%FY2025 · SEC7th of 850th22nd0.0%FY2025 · SEC4th of 873rd42nd-74.5%FY2025 · SEC8th of 832nd14th1.6%FY2025 · SEC3rd of 874th44th-2.4%FY2025 · SEC5th of 871st39th-1.2%8 ranked
Return on invested capital (Higher is better)————7.7%FY2025 · SEC1st of 328th32nd6.8%FY2025 · SEC2nd of 327th28th————0.6%FY2025 · SEC3rd of 35th2nd————————————6.8%3 ranked
Valuation
P/E ratio (Better neither way: ranked highest first)18.1×price Oct 28, 2026 · Market data5th of 627th47th34.9×price Oct 26, 2026 · Market data4th of 654th78th52.6×price Oct 28, 2026 · Market data3rd of 673rd88th————65.2×price Oct 9, 2026 · Market data2nd of 679th91st————6.0×price Oct 28, 2026 · Market data6th of 67th6th210.1×price Oct 29, 2026 · Market data1st of 696th97th43.7×6 ranked
Price to sales (Better neither way: ranked highest first)2.4×price Oct 28, 2026 · Market data5th of 739th53rd3.5×price Oct 26, 2026 · Market data4th of 749th66th4.0×price Oct 28, 2026 · Market data3rd of 751st71st5.0×price Oct 30, 2026 · Market data2nd of 757th77th1.8×price Oct 9, 2026 · Market data6th of 731st45th————1.3×price Oct 28, 2026 · Market data7th of 722nd36th5.3×price Oct 29, 2026 · Market data1st of 758th78th3.5×7 ranked
Price to book (Better neither way: ranked highest first)1.8×price Oct 28, 2026 · Market data7th of 835th43rd3.5×price Oct 26, 2026 · Market data5th of 856th67th6.9×price Oct 28, 2026 · Market data3rd of 876th83rd28.1×price Oct 30, 2026 · Market data2nd of 895th97th1.9×price Oct 9, 2026 · Market data6th of 836th44th48.0×price Oct 27, 2026 · Market data1st of 898th98th1.2×price Oct 28, 2026 · Market data8th of 823rd28th6.4×price Oct 29, 2026 · Market data4th of 873rd81st4.9×8 ranked
Free cash flow yield (Higher is better)0.0%price Oct 28, 2026 · Market data7th of 868th37th3.9%price Oct 26, 2026 · Market data3rd of 882nd59th4.8%price Oct 28, 2026 · Market data2nd of 886th65th0.8%price Oct 30, 2026 · Market data6th of 871st40th2.3%price Oct 9, 2026 · Market data4th of 876th48th-1.4%price Oct 27, 2026 · Market data8th of 863rd33rd6.1%price Oct 28, 2026 · Market data1st of 890th72nd1.5%price Oct 29, 2026 · Market data5th of 874th44th1.9%8 ranked
Financial strength
Debt to equity (Lower is better)0.8×FY2025 · SEC5th of 671st62nd0.5×FY2025 · SEC2nd of 652nd41st1.6×FY2025 · SEC6th of 686th81st————0.6×FY2025 · SEC4th of 660th50th————0.5×FY2025 · SEC3rd of 652nd42nd0.1×FY2025 · SEC1st of 625th18th0.5×6 ranked
Net debt to EBITDA (Lower is better)7.6×FY2025 · SEC5th of 593rd91st0.9×FY2025 · SEC2nd of 539th33rd3.7×FY2025 · SEC3rd of 576th70th————3.9×FY2025 · SEC4th of 577th72nd————0.7×FY2025 · SEC1st of 537th30th————3.7×5 ranked
Interest cover (Higher is better)————————8.1×FY2025 · SEC1st of 289th80th————0.5×FY2025 · SEC2nd of 272nd49th————————————4.3×2 ranked
Piotroski F-score (Higher is better)5 of 9FY2025 · SEC6th of 67 of 9FY2025 · SEC1st of 67 of 9FY2025 · SEC1st of 6——6 of 9FY2025 · SEC5th of 6——7 of 9FY2025 · SEC1st of 67 of 9FY2025 · SEC1st of 67.0 of 96 ranked
Scorecard
Scorecard (Higher is better)12 of 27FY2025 · Scorecard4th of 817 of 24FY2025 · Scorecard1st of 812 of 27FY2025 · Scorecard4th of 87 of 21FY2025 · Scorecard7th of 810 of 27FY2025 · Scorecard6th of 81 of 10FY2025 · Scorecard8th of 815 of 23FY2025 · Scorecard2nd of 812 of 23FY2025 · Scorecard3rd of 844% passed8 ranked
Valuation checks (Higher is better)4 of 6FY2025 · Scorecard2nd of 81 of 6FY2025 · Scorecard4th of 80 of 6FY2025 · Scorecard5th of 80 of 5FY2025 · Scorecard5th of 82 of 6FY2025 · Scorecard3rd of 80 of 4FY2025 · Scorecard5th of 85 of 6FY2025 · Scorecard1st of 80 of 6FY2025 · Scorecard5th of 88% passed8 ranked
Growth checks (Higher is better)1 of 6FY2025 · Scorecard6th of 86 of 6FY2025 · Scorecard1st of 82 of 6FY2025 · Scorecard5th of 84 of 6FY2025 · Scorecard3rd of 81 of 6FY2025 · Scorecard6th of 80 of 1FY2025 · Scorecard8th of 83 of 6FY2025 · Scorecard4th of 85 of 6FY2025 · Scorecard2nd of 842% passed8 ranked
Profitability checks (Higher is better)0 of 5FY2025 · Scorecard7th of 84 of 6FY2025 · Scorecard1st of 83 of 6FY2025 · Scorecard2nd of 81 of 5FY2025 · Scorecard5th of 82 of 6FY2025 · Scorecard4th of 80 of 3FY2025 · Scorecard7th of 82 of 5FY2025 · Scorecard3rd of 81 of 5FY2025 · Scorecard5th of 827% passed8 ranked
Financial health checks (Higher is better)4 of 5FY2025 · Scorecard3rd of 85 of 5FY2025 · Scorecard1st of 84 of 6FY2025 · Scorecard5th of 82 of 3FY2025 · Scorecard5th of 84 of 6FY2025 · Scorecard5th of 81 of 2FY2025 · Scorecard8th of 84 of 5FY2025 · Scorecard3rd of 85 of 5FY2025 · Scorecard1st of 873% passed8 ranked
Shareholder returns checks (Higher is better)3 of 5FY2025 · Scorecard5th of 71 of 1FY2025 · Scorecard1st of 73 of 3FY2025 · Scorecard1st of 70 of 2FY2025 · Scorecard7th of 71 of 3FY2025 · Scorecard6th of 7——1 of 1FY2025 · Scorecard1st of 71 of 1FY2025 · Scorecard1st of 7100% passed7 ranked
Ownership
Held by institutions (Better neither way: ranked highest first)115.0%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 8104.3%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 8107.9%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 8107.4%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 8101.1%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 820.9%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in8th of 8124.9%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 8105.7%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 8106.6%8 ranked
Institutions holding (Better neither way: ranked highest first)3882026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 84242026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 83582026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 83212026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 83122026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 81422026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in8th of 84102026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 82862026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 83408 ranked
Institutional holding, change over the quarter (Better neither way: ranked highest first)+5.0 pp2026-Q2 against 2026-Q1 · 13F4th of 8+5.3 pp2026-Q2 against 2026-Q1 · 13F2nd of 8+4.8 pp2026-Q2 against 2026-Q1 · 13F5th of 8+0.1 pp2026-Q2 against 2026-Q1 · 13F8th of 8+4.1 pp2026-Q2 against 2026-Q1 · 13F6th of 8+3.6 pp2026-Q2 against 2026-Q1 · 13F7th of 8+8.8 pp2026-Q2 against 2026-Q1 · 13F1st of 8+5.2 pp2026-Q2 against 2026-Q1 · 13F3rd of 8+4.9 pp8 ranked
Dividends
Dividend yield (Higher is better)1.1%FY2025 · SEConly one with it54th28th————————————————————————————1.1%—
Shareholder yield (Higher is better)6.5%FY2025 · SEC1st of 480th77th————3.2%FY2025 · SEC2nd of 462nd51st0.0%FY2025 · SEC4th of 47th3rd0.2%FY2025 · SEC3rd of 419th10th————————————1.7%4 ranked
Dividend per share (Better neither way: ranked highest first)$1.36FY2025 · SEConly one with it——————————————$1.36—

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Teleflex Incorporated: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Merit Medical Systems, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Haemonetics Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; iRhythm Technologies, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; ICU Medical, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Pulse Biosciences, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Envista Holdings Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; AtriCure, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
Teleflex Incorporated5.9%FY2025
66th percentile in Healthcaremedian -7.7%, 674 companies
58th percentile in USAmedian 3.5%, 2,595 companies
Merit Medical Systems, Inc.12.2%FY2025
76th percentile in Healthcaremedian -7.7%, 674 companies
73rd percentile in USAmedian 3.5%, 2,595 companies
Haemonetics Corporation11.8%FY2025
76th percentile in Healthcaremedian -7.7%, 674 companies
72nd percentile in USAmedian 3.5%, 2,595 companies
iRhythm Technologies, Inc.-7.7%FY2025
50th percentile in Healthcaremedian -7.7%, 674 companies
29th percentile in USAmedian 3.5%, 2,595 companies
ICU Medical, Inc.1.9%FY2025
61st percentile in Healthcaremedian -7.7%, 674 companies
45th percentile in USAmedian 3.5%, 2,595 companies
Pulse Biosciences, Inc.———
Envista Holdings Corporation8.0%FY2025
69th percentile in Healthcaremedian -7.7%, 674 companies
63rd percentile in USAmedian 3.5%, 2,595 companies
AtriCure, Inc.-1.8%FY2025
55th percentile in Healthcaremedian -7.7%, 674 companies
37th percentile in USAmedian 3.5%, 2,595 companies

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$711 M$1.4 B$2.1 B$2.8 B201020122014201620182020202220242026Teleflex Incorporated $2.0 BMerit Medical Systems, Inc. $1.5 BHaemonetics Corporation $1.3 BiRhythm Technologies, Inc. $747 MICU Medical, Inc. $2.2 BPulse Biosciences, Inc. $0 MEnvista Holdings Corporation $2.7 BAtriCure, Inc. $535 M

Rank in the group

1st2nd3rd4th5th6th7th8th201120122013201420152016201720182019202020212022202320242025Teleflex Incorporated: 1st of 5 in 2011Teleflex Incorporated: 1st of 5 in 2012Teleflex Incorporated: 1st of 5 in 2013Teleflex Incorporated: 1st of 6 in 2014Teleflex Incorporated: 1st of 6 in 2015Teleflex Incorporated: 1st of 6 in 2016Teleflex Incorporated: 2nd of 7 in 2017Teleflex Incorporated: 2nd of 7 in 2018Teleflex Incorporated: 1st of 7 in 2019Teleflex Incorporated: 1st of 7 in 2020Teleflex Incorporated: 1st of 8 in 2021Teleflex Incorporated: 1st of 8 in 2022Teleflex Incorporated: 3rd of 7 in 2023Teleflex Incorporated: 3rd of 7 in 2024Teleflex Incorporated: 3rd of 8 in 2025Teleflex IncorporatedMerit Medical Systems, Inc.: 3rd of 5 in 2011Merit Medical Systems, Inc.: 3rd of 5 in 2012Merit Medical Systems, Inc.: 3rd of 5 in 2013Merit Medical Systems, Inc.: 3rd of 6 in 2014Merit Medical Systems, Inc.: 3rd of 6 in 2015Merit Medical Systems, Inc.: 3rd of 6 in 2016Merit Medical Systems, Inc.: 5th of 7 in 2017Merit Medical Systems, Inc.: 5th of 7 in 2018Merit Medical Systems, Inc.: 4th of 7 in 2019Merit Medical Systems, Inc.: 4th of 7 in 2020Merit Medical Systems, Inc.: 4th of 8 in 2021Merit Medical Systems, Inc.: 5th of 8 in 2022Merit Medical Systems, Inc.: 5th of 7 in 2023Merit Medical Systems, Inc.: 5th of 7 in 2024Merit Medical Systems, Inc.: 4th of 8 in 2025Merit Medical Systems, IncHaemonetics Corporation: 2nd of 5 in 2011Haemonetics Corporation: 2nd of 5 in 2012Haemonetics Corporation: 2nd of 5 in 2013Haemonetics Corporation: 2nd of 6 in 2014Haemonetics Corporation: 2nd of 6 in 2015Haemonetics Corporation: 2nd of 6 in 2016Haemonetics Corporation: 4th of 7 in 2017Haemonetics Corporation: 4th of 7 in 2018Haemonetics Corporation: 5th of 7 in 2019Haemonetics Corporation: 5th of 7 in 2020Haemonetics Corporation: 5th of 8 in 2021Haemonetics Corporation: 4th of 8 in 2022Haemonetics Corporation: 4th of 7 in 2023Haemonetics Corporation: 4th of 7 in 2024Haemonetics Corporation: 5th of 8 in 2025Haemonetics CorporationiRhythm Technologies, Inc.: 6th of 6 in 2014iRhythm Technologies, Inc.: 6th of 6 in 2015iRhythm Technologies, Inc.: 6th of 6 in 2016iRhythm Technologies, Inc.: 7th of 7 in 2017iRhythm Technologies, Inc.: 7th of 7 in 2018iRhythm Technologies, Inc.: 7th of 7 in 2019iRhythm Technologies, Inc.: 6th of 7 in 2020iRhythm Technologies, Inc.: 6th of 8 in 2021iRhythm Technologies, Inc.: 6th of 8 in 2022iRhythm Technologies, Inc.: 6th of 7 in 2023iRhythm Technologies, Inc.: 6th of 7 in 2024iRhythm Technologies, Inc.: 6th of 8 in 2025iRhythm Technologies, Inc.ICU Medical, Inc.: 4th of 5 in 2011ICU Medical, Inc.: 4th of 5 in 2012ICU Medical, Inc.: 4th of 5 in 2013ICU Medical, Inc.: 4th of 6 in 2014ICU Medical, Inc.: 4th of 6 in 2015ICU Medical, Inc.: 4th of 6 in 2016ICU Medical, Inc.: 3rd of 7 in 2017ICU Medical, Inc.: 3rd of 7 in 2018ICU Medical, Inc.: 3rd of 7 in 2019ICU Medical, Inc.: 3rd of 7 in 2020ICU Medical, Inc.: 3rd of 8 in 2021ICU Medical, Inc.: 3rd of 8 in 2022ICU Medical, Inc.: 2nd of 7 in 2023ICU Medical, Inc.: 2nd of 7 in 2024ICU Medical, Inc.: 2nd of 8 in 2025ICU Medical, Inc.Pulse Biosciences, Inc.: 8th of 8 in 2021Pulse Biosciences, Inc.: 8th of 8 in 2022Pulse Biosciences, Inc.: 8th of 8 in 2025Pulse Biosciences, Inc.Envista Holdings Corporation: 1st of 7 in 2017Envista Holdings Corporation: 1st of 7 in 2018Envista Holdings Corporation: 2nd of 7 in 2019Envista Holdings Corporation: 2nd of 7 in 2020Envista Holdings Corporation: 2nd of 8 in 2021Envista Holdings Corporation: 2nd of 8 in 2022Envista Holdings Corporation: 1st of 7 in 2023Envista Holdings Corporation: 1st of 7 in 2024Envista Holdings Corporation: 1st of 8 in 2025Envista Holdings CorporatiAtriCure, Inc.: 5th of 5 in 2011AtriCure, Inc.: 5th of 5 in 2012AtriCure, Inc.: 5th of 5 in 2013AtriCure, Inc.: 5th of 6 in 2014AtriCure, Inc.: 5th of 6 in 2015AtriCure, Inc.: 5th of 6 in 2016AtriCure, Inc.: 6th of 7 in 2017AtriCure, Inc.: 6th of 7 in 2018AtriCure, Inc.: 6th of 7 in 2019AtriCure, Inc.: 7th of 7 in 2020AtriCure, Inc.: 7th of 8 in 2021AtriCure, Inc.: 7th of 8 in 2022AtriCure, Inc.: 7th of 7 in 2023AtriCure, Inc.: 7th of 7 in 2024AtriCure, Inc.: 7th of 8 in 2025AtriCure, Inc.
Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearTeleflex IncorporatedMerit Medical Systems, Inc.Haemonetics CorporationiRhythm Technologies, Inc.ICU Medical, Inc.Pulse Biosciences, Inc.Envista Holdings CorporationAtriCure, Inc.
2025$2.0 BSEC3rd$1.5 BSEC4th$1.3 BSEC5th$747 MSEC6th$2.2 BSEC2nd$0 MSEC8th$2.7 BSEC1st$535 MSEC7th
2024$1.7 BSEC3rd$1.4 BSEC5th$1.4 BSEC4th$592 MSEC6th$2.4 BSEC2nd—$2.5 BSEC1st$465 MSEC7th
2023$1.7 BSEC3rd$1.3 BSEC5th$1.3 BSEC4th$493 MSEC6th$2.3 BSEC2nd—$2.6 BSEC1st$399 MSEC7th
2022$2.8 BSEC1st$1.2 BSEC5th$1.2 BSEC4th$411 MSEC6th$2.3 BSEC3rd$1 MSEC8th$2.6 BSEC2nd$330 MSEC7th
2021$2.8 BSEC1st$1.1 BSEC4th$993 MSEC5th$323 MSEC6th$1.3 BSEC3rd$1 MSEC8th$2.5 BSEC2nd$274 MSEC7th
2020$2.5 BSEC1st$964 MSEC4th$870 MSEC5th$265 MSEC6th$1.3 BSEC3rd—$1.9 BSEC2nd$207 MSEC7th
2019$2.6 BSEC1st$995 MSEC4th$988 MSEC5th$215 MSEC7th$1.3 BSEC3rd—$2.3 BSEC2nd$231 MSEC6th
2018$2.4 BSEC2nd$883 MSEC5th$968 MSEC4th$147 MSEC7th$1.4 BSEC3rd—$2.8 BSEC1st$202 MSEC6th
2017$2.1 BSEC2nd$728 MSEC5th$904 MSEC4th$99 MSEC7th$1.3 BSEC3rd—$2.8 BSEC1st$175 MSEC6th
2016$1.9 BSEC1st$604 MSEC3rd$886 MSEC2nd$64 MSEC6th$379 MSEC4th——$155 MSEC5th
2015$1.8 BSEC1st$542 MSEC3rd$909 MSEC2nd$36 MSEC6th$342 MSEC4th——$130 MSEC5th
2014$1.8 BSEC1st$510 MSEC3rd$910 MSEC2nd$22 MSEC6th$309 MSEC4th——$107 MSEC5th

Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Teleflex Incorporated#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Merit Medical Systems, Inc.MMSI · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $5.6 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $5.6 B (Oct 26, 2026) · revenue $1.5 B (year to December 2025)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    In the group
  • Haemonetics CorporationHAE · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $5.5 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $5.5 B (Oct 28, 2026) · revenue $1.3 B (year to March 2026)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    In the group
  • iRhythm Technologies, Inc.IRTC · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $4.3 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $4.3 B (Oct 30, 2026) · revenue $747 M (year to December 2025)
    98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)
    In the group
  • ICU Medical, Inc.ICUI · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $3.9 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $3.9 B (Oct 9, 2026) · revenue $2.2 B (year to December 2025)
    98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)
    In the group
  • Pulse Biosciences, Inc.PLSE · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $3.9 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $3.9 B (Oct 27, 2026) · revenue $0 M (year to December 2025)
    98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)
    In the group
  • Envista Holdings CorporationNVST · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $3.8 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $3.8 B (Oct 28, 2026) · revenue $2.7 B (year to December 2025)
    98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)
    In the group
  • AtriCure, Inc.ATRC · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $3.1 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $3.1 B (Oct 29, 2026) · revenue $535 M (year to December 2025)
    96 of 100 (industry or sector 50 + size 26 + country 15 + figures on file 5)
    In the group
  • The Cooper Companies, Inc.COO · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $11.3 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $11.3 B (Oct 29, 2026) · revenue $4.1 B (year to October 2025)
    95 of 100 (industry or sector 50 + size 25 + country 15 + figures on file 5)
    + Add
  • Repligen CorporationRGEN · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $11.5 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $11.5 B (Oct 27, 2026) · revenue $738 M (year to December 2025)
    95 of 100 (industry or sector 50 + size 25 + country 15 + figures on file 5)
    + Add
  • Baxter International Inc.BAX · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $12.9 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $12.9 B (Oct 28, 2026) · revenue $11.2 B (year to December 2025)
    94 of 100 (industry or sector 50 + size 25 + country 15 + figures on file 5)
    + Add
  • Glaukos CorporationGKOS · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $14.4 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $14.4 B (Oct 30, 2026) · revenue $507 M (year to December 2025)
    94 of 100 (industry or sector 50 + size 24 + country 15 + figures on file 5)
    + Add
  • LeMaitre Vascular, Inc.LMAT · 🇺🇸 USA
    Same industry: Medical Instruments · Similar size: $1.9 B market cap against $5.5 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $1.9 B (Oct 22, 2026) · revenue $250 M (year to December 2025)
    93 of 100 (industry or sector 50 + size 23 + country 15 + figures on file 5)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.